These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 19353483

  • 1. [Pharmacokinetic MRI of the prostate: parameters for differentiating low-grade and high-grade prostate cancer].
    Franiel T, Lüdemann L, Taupitz M, Rost J, Asbach P, Beyersdorff D.
    Rofo; 2009 Jun; 181(6):536-42. PubMed ID: 19353483
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
    Franiel T, Lüdemann L, Rudolph B, Rehbein H, Staack A, Taupitz M, Prochnow D, Beyersdorff D.
    Invest Radiol; 2008 Jul; 43(7):481-7. PubMed ID: 18580330
    [Abstract] [Full Text] [Related]

  • 3. MRI before and after external beam intensity-modulated radiotherapy of patients with prostate cancer: the feasibility of monitoring of radiation-induced tissue changes using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
    Franiel T, Lüdemann L, Taupitz M, Böhmer D, Beyersdorff D.
    Radiother Oncol; 2009 Nov; 93(2):241-5. PubMed ID: 19748143
    [Abstract] [Full Text] [Related]

  • 4. Effects of water exchange on MRI-based determination of relative blood volume using an inversion-prepared gradient echo sequence and a blood pool contrast medium.
    Carreira GC, Gemeinhardt O, Beyersdorff D, Schnorr J, Taupitz M, Lüdemann L.
    Magn Reson Imaging; 2009 Apr; 27(3):360-9. PubMed ID: 18768279
    [Abstract] [Full Text] [Related]

  • 5. Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
    Gemeinhardt O, Lüdemann L, Prochnow D, Abramjuk C, Taupitz M, Hamm B, Beyersdorff D.
    Rofo; 2005 Jul; 177(7):935-9. PubMed ID: 15973594
    [Abstract] [Full Text] [Related]

  • 6. Differentiation of prostate cancer from normal prostate tissue: role of hotspots in pharmacokinetic MRI and histologic evaluation.
    Franiel T, Lüdemann L, Rudolph B, Lutterbeck E, Hamm B, Beyersdorff D.
    AJR Am J Roentgenol; 2010 Mar; 194(3):675-81. PubMed ID: 20173144
    [Abstract] [Full Text] [Related]

  • 7. Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.
    Kim JK, Hong SS, Choi YJ, Park SH, Ahn H, Kim CS, Cho KS.
    J Magn Reson Imaging; 2005 Nov; 22(5):639-46. PubMed ID: 16200542
    [Abstract] [Full Text] [Related]

  • 8. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T, Wada A, Hayashi T, Uchida K, Sumura M, Uchida N, Kitagaki H, Igawa M.
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [Abstract] [Full Text] [Related]

  • 9. Prostate MR imaging: tissue characterization with pharmacokinetic volume and blood flow parameters and correlation with histologic parameters.
    Franiel T, Lüdemann L, Rudolph B, Rehbein H, Stephan C, Taupitz M, Beyersdorff D.
    Radiology; 2009 Jul; 252(1):101-8. PubMed ID: 19561252
    [Abstract] [Full Text] [Related]

  • 10. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
    Lowry M, Zelhof B, Liney GP, Gibbs P, Pickles MD, Turnbull LW.
    Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
    [Abstract] [Full Text] [Related]

  • 11. Principal component analysis of dynamic contrast enhanced MRI in human prostate cancer.
    Eyal E, Bloch BN, Rofsky NM, Furman-Haran E, Genega EM, Lenkinski RE, Degani H.
    Invest Radiol; 2010 Apr; 45(4):174-81. PubMed ID: 20177391
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous quantification of perfusion and permeability in the prostate using dynamic contrast-enhanced magnetic resonance imaging with an inversion-prepared dual-contrast sequence.
    Lüdemann L, Prochnow D, Rohlfing T, Franiel T, Warmuth C, Taupitz M, Rehbein H, Beyersdorff D.
    Ann Biomed Eng; 2009 Apr; 37(4):749-62. PubMed ID: 19169821
    [Abstract] [Full Text] [Related]

  • 13. Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging.
    Kitajima K, Kaji Y, Fukabori Y, Yoshida K, Suganuma N, Sugimura K.
    J Magn Reson Imaging; 2010 Mar; 31(3):625-31. PubMed ID: 20187206
    [Abstract] [Full Text] [Related]

  • 14. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
    Ocak I, Bernardo M, Metzger G, Barrett T, Pinto P, Albert PS, Choyke PL.
    AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [MRI of prostate cancer using three different coil systems: image quality, tumor detection, and staging].
    Beyersdorff D, Darsow U, Stephan C, Schnorr D, Loening S, Taupitz M.
    Rofo; 2003 Jun; 175(6):799-805. PubMed ID: 12811693
    [Abstract] [Full Text] [Related]

  • 17. Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours.
    Cirillo S, Petracchini M, Della Monica P, Gallo T, Tartaglia V, Vestita E, Ferrando U, Regge D.
    Clin Radiol; 2008 Aug; 63(8):871-9. PubMed ID: 18625351
    [Abstract] [Full Text] [Related]

  • 18. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA.
    Padhani AR, Gapinski CJ, Macvicar DA, Parker GJ, Suckling J, Revell PB, Leach MO, Dearnaley DP, Husband JE.
    Clin Radiol; 2000 Feb; 55(2):99-109. PubMed ID: 10657154
    [Abstract] [Full Text] [Related]

  • 19. Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens.
    Puech P, Potiron E, Lemaitre L, Leroy X, Haber GP, Crouzet S, Kamoi K, Villers A.
    Urology; 2009 Nov; 74(5):1094-9. PubMed ID: 19773038
    [Abstract] [Full Text] [Related]

  • 20. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
    Haider MA, Chung P, Sweet J, Toi A, Jhaveri K, Ménard C, Warde P, Trachtenberg J, Lockwood G, Milosevic M.
    Int J Radiat Oncol Biol Phys; 2008 Feb 01; 70(2):425-30. PubMed ID: 17881141
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.